IBM

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

–

Return

+0.23%

Status

scored

Trim to approximately 50% of benchmark weight immediately via market orders at $218-224 over 1-2 weeks, holding residual ≤1% of portfolio through the October 21 Q3 print. Maintain a hard stop at $215 close-only (providing a 1.2x ATR buffer on the 6.32 ATR), with re-entry only post-Q3 using a three-condition framework: close above $232 on volume ≥8M for two consecutive sessions, 50 SMA flattening, and organic Q3 beat with raised guidance. No hedge overlay is recommended, as the structural floor and 3% dividend yield on residual already provide downside protection.

Outcome

✗

Return

+2.77%

Status

scored

Trim 50% of IBM via market orders or near-market limits at $218-222 over 1-2 weeks (not waiting for a $230 rally that may never materialize), while holding residual ≤1% portfolio weight through the Q3 October 21 earnings catalyst with a hard stop at $205. Trim an additional 10-20% on any $230-232 rally within a 10-session window; if no rally occurs, force-reassess the position entirely. Q3 earnings serve as the binary resolution point: a clean beat with close above the 50 SMA ($231) on volume ≥40M triggers adding back 15-20% of the trim, while a miss or conservative guide requires exiting the residual to zero by the next session open.

Outcome

–

Return

-0.35%

Status

scored

IBM rating lowered to Underweight with directive to trim 50% of position via market orders or near-market limits ($218-222) over 1-2 weeks, replacing the trader's inadequate 51-cent stop with a $215.00 close-only stop below the September 30 swing low. Mandatory Q3 2026 earnings reassessment (late October) serves as the binary catalyst, with a 10-session cap on any trim-into-strength rule at $231-232 to prevent the passive-long trap observed in prior iterations.

Outcome

✓

Return

-0.13%

Status

scored

IBM receives a HOLD rating defined as explicit trim discipline rather than passive full retention. The decision mandates trimming 25-33% of the position into any relief rally to $231-232 without a fundamental catalyst, while prohibiting new capital deployment at current levels. Hard stop is set at $213.00 close-only with a catastrophic stop at $197.00 close-only, and the position should be sized to allow additions on a confirmed Q3 earnings beat and exits on a confirmed miss without forced selling.

Outcome

✓

Return

-0.48%

Status

scored

Light Underweight with 25-30% trim recommended over 1-2 weeks via market orders or near-market limits ($218-222), rejecting the Hold consensus per binding 10/01 reflection that explicitly mandates trim on confirmed downtrend with MACD bearish. Structural floor (beta 0.71, $12B FCF, 1.9x dividend coverage, Aristocrat streak) is retained as 70-75% residual with hard stop at $214.75 and catastrophic stop at $200; no hedge overlay per binding reflection logic.

Outcome

✓

Return

-1.32%

Status

scored

Maintain IBM as a HOLD-rated yield-and-quality holding; trim 10-20% into strength toward $231-233 but do not add on weakness as $215.92 Bollinger lower band represents the higher-probability near-term destination. Optional long $215 / short $200 put spread hedge for income-mandate positions, with hard stop at $215.92 and catastrophic stop at $200; re-entry requires close above $226.53 with MACD cross and volume ≥6M or above $234 with MACD positive flip targeting $244-249.

Outcome

✗

Return

+2.59%

Status

scored

Trim 25-30% of IBM via market orders or near-market limits at $218-222 over 1-2 weeks, sized to 50-75% of benchmark weight (Underweight but not zero), with no hedge overlay as the structural floor (beta 0.71, $12B FCF, 1.9x dividend coverage) serves as the built-in hedge. Hard stop on residual at $209 close-only; catastrophic stop at $200; single re-entry trigger at $234 close with volume ≥6M and MACD histogram positive flip.

Outcome

✗

Return

-0.03%

Status

scored

Trim IBM 25-30% to reduce exposure to 70-75% of benchmark weight over 1-2 weeks via market orders or near-market limits ($218-222), avoiding tiered ladders that depend on rallies the bearish thesis contradicts. Hard stop on residual at $209 close-only with catastrophic stop at $200; re-enter only if IBM closes above $234 on volume ≥6M with MACD histogram positive flip.

Outcome

–

Return

-0.31%

Status

scored

Reduce IBM exposure by approximately 50% over the next 1–2 weeks using market orders or near-market limit orders ($218–220), replacing the proposed tiered ladder at $228–234/$240+. Retain the remaining 50% as a defensive position for Q3 earnings optionality (late October) and dividend carry, with a hard stop at $209.00 close-only. The single re-entry trigger is a close above $234 on volume ≥6M with MACD histogram positive flip; no hedge overlay is prescribed since the structural floor (beta 0.71, $12B FCF, 1.9x dividend coverage) already provides insurance.

Outcome

✓

Return

-2.15%

Status

scored

Trim 50-55% of IBM position via tiered execution (25% at market, 25-30% on limits at $228-232) with 5% core retention sized to absorb 15-20% drawdown, hard stop at $211 close-only (July crash low) with secondary $200 stop. Hedge overlay with $215-strike puts for 3-month expiry (Q3 earnings binary protection) plus TLT puts for duration-short pair ($54.8B net debt rate sensitivity). Re-enter on close above $235 with positive MACD and volume ≥6M.

Outcome

✓

Return

-0.68%

Status

scored

Trim 35-40% of IBM via tiered execution (15% at market, 20-25% on limit orders into $230-$234 rally), retaining 60-65% residual for Q3 HashiCorp optionality and 2.90% dividend carry. Layer duration-short hedge (TLT puts) and $215-220 strike put protection; hard stop at $215.00 close-only.

Outcome

✓

Return

-2.45%

Status

scored

IBM receives an Underweight rating with a $220 price target and 4-6 week tactical horizon through Q3 earnings. The recommendation calls for a 15-20% trim with a hedge overlay using long-dated puts at $215-220 strike or TLT puts, while maintaining income mandates at benchmark weight; total-return mandates should reduce to 70-80% of benchmark weight. Hard stop is set at $215 close-only on residual, with re-entry triggers on Q3 beat-and-raise or a close above $237 on volume ≥6M.

Outcome

✗

Return

+0.60%

Status

scored

Underweight IBM with a trim recommendation of 30-35% of the position on relief rallies toward $235-240, retaining 65-70% to capture Q3 binary option value and dividend carry. Hard stop on the residual at $215.00 close-only, with a layered hedge overlay including TLT puts, ACN/MSFT relative-value hedge, and put protection on the remaining position.

Outcome

✓

Return

-0.24%

Status

scored

The portfolio manager is overriding all analyst recommendations (Underweight, Sell, and varying trim proposals) to maintain a HOLD rating at current weight, citing the 9/18 reflection that trim friction has been alpha-destructive in 3 of 3 Underweight iterations since 9/16 on this exact configuration. With no fresh forward-confirmation of breakdown materialized since 9/18, the default-to-Hold directive applies. A hard stop at $215.00 close-only will be triggered only on confirmed capitulation below the July 14 panic floor, preserving the 2.7-2.8% dividend yield and asymmetric Q3 earnings option value while avoiding transaction friction on a name with documented structural floor ($12B FCF, 1.9x dividend coverage, 28-year Aristocrat streak).

Outcome

✗

Return

+1.04%

Status

scored

The analyst overrides a unanimous Hold consensus to Underweight based on the prior decision log's 9/17 lesson, which directly matches the current setup (close below 50 SMA, MACD flipping negative after 13 consecutive positive bars, RSI at 44, awaiting Q3 binary catalyst). The calibrated 20-25% trim is larger than the warned-against 10-15% "no-man's-land" but smaller than the 30%+ "dominate sizing" that would sacrifice asymmetric Q3 option value. Re-entry triggers are Q3 HashiCorp beat-and-raise or close above $237 on volume ≥6M; Sell trigger is close below $215 on volume >30M.

Outcome

✓

Return

-3.45%

Status

scored

Underweight IBM with a 30-40% trim recommendation, maintaining residual exposure for income mandates given the 2.85% dividend yield. Re-engage on close above $247 with volume exceeding 6M shares; hard stop floor at $215 close-only with Q3 2026 earnings in late October as the binary resolution catalyst.

Outcome

–

Return

+0.11%

Status

scored

Trim IBM 10-15% at market to reduce gross exposure into the Q3 late-October earnings catalyst while preserving foundry/HashiCorp upside optionality; maintain residual position with $215 close-only stop. Re-entry triggers are Q3 beat-and-raise with HashiCorp disclosure, or technical breakout above $247 on volume >6M with follow-through, or regime change above $258 on volume >10M.

Outcome

✗

Return

-4.38%

Status

scored

The analysts recommend maintaining a Hold on IBM, rejecting the Aggressive Analyst's SELL recommendation due to an entry stop at $265 that is too tight relative to the stock's 7.22 ATR and demonstrated gap risk. The Neutral Analyst's trim zone ($250-265) is deemed conditional on a rally that current technicals don't support, with mean-reversion likely pulling price DOWN toward the 50 SMA at $237 rather than UP toward the 200 SMA at $258. The decision log is dispositive: four Underweight iterations destroyed alpha while three consecutive Holds captured +6.8% combined alpha through disciplined inaction around binary events.

Outcome

✓

Return

-0.29%

Status

scored

Maintain IBM at current weight with a Hold rating at $243, rejecting both the Research Manager's Underweight and Trader's Sell recommendations. The bear case is intellectually valid but empirically alpha-destroying: prior Underweight trims (9/10/2026: -3.1% alpha) have consistently destroyed relative performance through transaction friction into the same binary catalyst, while Hold iterations have captured +2.8% alpha. Execute disciplined downside stops at $228 (50% reduction) and $215 (full re-evaluation), with any rally to the $250-258 resistance zone serving as opportunistic trim opportunity for overweight accounts.

Outcome

✗

Return

+2.38%

Status

scored

Analysts unanimously recommend holding current weight into Q3 2026 earnings (late October) despite directional disagreement. The prior 9/10 Underweight trim produced +4.0% raw return but +3.1% alpha loss, demonstrating that transaction friction on this low-beta quality name destroys alpha; four consecutive Underweight iterations averaged zero alpha after costs versus +3.8% alpha from the 9/8 Hold. Entry triggers are either a pullback to $222-$228 with RSI bullish divergence (~2:1 R/R) or breakout above $258 on volume ≥10M, with $228 close below on >5M volume as the hard stop and $250-$258 as the trim zone for any overweight positions.

Outcome

✗

Return

+3.96%

Status

scored

Trim IBM to 70% residual position via immediate-at-market execution (reject staged tranches at $240-242 which sit at overhead resistance), with close-only stops at $228 (halve residual) and $215 (exit residual). Optional defined-risk hedge via put spread (e.g., buy $235/sell $215) at 1-1.5% notional rather than naked short to avoid 2.82% dividend drag. Re-evaluate after Q3 2026 earnings in late October, with upgrade triggers at $242+ volume confirmation or downgrade trigger at $215 with elevated volume.

Outcome

✗

Return

-2.47%

Status

scored

Maintain Hold rating on IBM for the 2.88% dividend yield and FCF floor, avoiding fresh equity at $240. For accounts adding exposure, use half-size maximum with defined entry triggers at $228-234 on stabilizing volume or $215-220 on a stabilizing flush. Full upgrade requires close above $258 (200 SMA) on ≥10M shares with follow-through; downgrade only on daily close below $215 on >30M shares. Resolution catalyst is Q3 2026 earnings in late October.

Outcome

✗

Return

+3.38%

Status

scored

Maintain HOLD rating at $232 with $215 price target; adopt simplified single-leg tactical overlay rather than the multi-leg structures that produced net-zero alpha across four prior Underweight iterations. Trim 25-50% of position on rallies toward $239.55 (50 SMA rejection zone), sell covered calls at $240 strikes, and for income accounts sell cash-secured puts at $215-220 strikes for 8-9% annualized premium; only add equity on confirmed daily close above $239.55 on volume ≥25M shares. Q3 2026 earnings (late October) is the decisive binary catalyst.

Outcome

–

Return

-1.19%

Status

scored

Trim 35-40% of IBM position via immediate-at-market execution, retaining residual as a defined-risk income sleeve with a two-tier stop framework ($220 daily close = halve residual, $211.70 daily close = full exit). Layer October expiry covered calls at $250-$260 strike (widened from prior $245-$250 per reflection that strikes never approached price, capping premium capture), targeting 1.0-1.8% premium income. Q3 2026 earnings (late October) serves as the binary catalyst for next sizing decision, with upgrade to Hold triggered by confirmed close above $242 on volume >6M with RSI >55 and expanding MACD histogram.

Outcome

✗

Return

+0.08%

Status

scored

Trim IBM position by 45% via immediate-at-market execution to Underweight while retaining 55% residual as an income-generating defined-risk sleeve, rather than escalating to full Sell given IBM's $12B TTM FCF and 1.9x dividend coverage providing genuine structural support. Deploy covered calls at $250-$260 strike (widened from prior $245-$250), with a two-tier stop framework at $220 daily close (halve residual) and $211.70 daily close (full exit), with Q3 2026 earnings in late October serving as the binary catalyst for next sizing decision.

Outcome

✗

Return

+1.30%

Status

scored

Execute immediate-at-market trim of approximately 45% of IBM position, holding the residual as a defined-risk income sleeve rather than a directional bet. Implement a two-tier stop framework with $220 daily close triggering a halve of the residual position and $211.70 daily close triggering full exit, while layering covered calls at $250-$260 strike for October expiry to convert passive exposure into income-generating relative-value structure. Re-engagement to Hold requires confirmed close above $242 on volume greater than 6M with RSI greater than 55 and expanding MACD histogram.

Outcome

–

Return

+0.13%

Status

scored

Trim IBM 45-50% immediately at market while retaining ~25% residual as a defined-risk income sleeve, converting passive Underweight into income-generating relative-value structure via covered calls at $245-$250 strike for October expiry. The Q2 2026 revenue deceleration from +7.6% to +1.1% raises probability of consensus EPS estimate cuts, and technicals (price below all declining MAs with MACD lines still negative at -0.96) argue for defensive sizing, while the FCF floor ($12B TTM, dividend covered 1.8-1.9x) and Q3 binary catalyst ($242 re-entry upgrade trigger) cap the bearish case at Underweight rather than full exit.

Outcome

–

Return

-1.06%

Status

scored

Trim approximately 50% of IBM position immediately at market execution, retaining a residual income sleeve rather than a directional bet. Set the residual stop at $247 (just above the 50 SMA at $242.50), layer covered calls at $245-$250 strike for October expiry, and designate $227 as the explicit breakdown trigger for full exit; re-evaluation warranting upgrade to Hold requires confirmed close above $247 on volume >6M with RSI >55 and expanding MACD histogram.

Outcome

✓

Return

-0.73%

Status

scored

Maintain IBM position with mandatory covered-call overlay at $245-$250 strike for October/November expiry to address alpha bleed from drift erosion in the compression-below-declining-MAs setup. Do not add on pullbacks to $227-$229 or trim — the $12B FCF floor, 1.9x dividend coverage, and 0.705 beta preserve option value into Q3 2026 earnings.

Outcome

✓

Return

-1.34%

Status

scored

Maintain IBM at current exposure with a conditional 15% starter trigger that activates only after Jackson Hole clears on Aug 28 without hawkish shock and IBM closes above $233 on confirmed daily closes; convert the $233 stop from intraday to daily-close invalidation to avoid whipsaw given IBM's $7.73 ATR. Preserve the existing 33%/33% scale-in framework at $243 (50 SMA) and $261 (200 SMA), and layer an October expiry covered-call overlay at $245-$250 strike to convert passive Hold into yield-and-catalyst structure.

Outcome

✗

Return

+3.88%

Status

scored

Trim IBM to below benchmark weight via immediate-at-market execution given the technical structure is damaged with price $13 below the declining 50 SMA and 80% MACD histogram collapse in 11 sessions. Hard stop at $222.30 (Bollinger lower band) on residual position, with covered calls at $245-$250 strike for October expiry to convert passive exposure into income-generating relative-value structure. No fresh initiation; use rallies toward the 50 SMA at $243 as additional trim opportunities.

Outcome

✓

Return

-1.84%

Status

scored

Trim IBM 25% to ~75% residual core position via immediate-at-market execution at $234.19, retaining the income stream ($12B FCF, 1.9x dividend coverage) and Q3 earnings optionality; layer covered calls at $245–$250 strike for October expiry to convert passive Underweight into income-generating relative-value structure. Hard stop on residual at $221.55 (not $232, which sits only 0.3% below entry against ~$7.65 ATR and would whipsaw); no fresh initiation.

Outcome

✗

Return

+1.36%

Status

scored

Trim IBM by ~25% via immediate-at-market execution while retaining ~75% core position for dividend/FCF ballast, with a hard stop at $204. Sell covered calls at $245-$250 strike against the residual for October expiry to generate 1.5-2.5% premium income and cap participation at the 50 SMA reclaim level.

Outcome

✓

Return

-1.97%

Status

scored

Trim IBM to Underweight via immediate-at-market execution, capturing ~80% of the ~15% downside asymmetry while preserving the defensive ballast ($12B FCF, 1.8x dividend coverage, 0.705 beta) and option value into Q3 2026 earnings as the binary catalyst. Hard stop at $215.52; do not add at $235.68.

Outcome

–

Return

+0.85%

Status

scored

Trim IBM by 25% in tranches—15% now at market and 10% additional at $240-245 if price reaches the declining 50 SMA on declining volume—while retaining 70-75% residual core for the 4.4% dividend yield and 1.9x FCF coverage. Hard stop on residual at $215 (July low plus lower Bollinger band), with explicit exit triggers including fraud escalation, Q3 miss with guidance reset, close below $200, or dividend cut. The rating remains Underweight (equivalent to Sell) rather than full Sell due to the quantitative FCF floor ($12B TTM), IBM's defensive ballast (0.705 beta, 20+ year dividend history), and the Q3 2026 earnings binary catalyst in late October.

Outcome

✓

Return

-1.46%

Status

scored

Portfolio Manager maintains HOLD on IBM at $237, rejecting both the aggressive analyst's coiled-spring initiation case and the neutral analyst's starter-add refinement. Key drivers are unresolved operating income contraction (-7.7% YoY), absent volume confirmation (5.31M vs. 67.4M capitulation), and securities fraud tail risk, balanced against a credible FCF floor (5.4% yield, 1.9× dividend coverage) and a binary Q3 2026 earnings catalyst. The decision preserves optionality: wait for $247 break (50% add trigger) or $204 breakdown (trim trigger).

Outcome

✓

Return

+1.93%

Status

scored

Maintain existing IBM exposure at $232.67 with a corrected stop at $215.50 (7.3% risk vs. the broken $232 stop that risked whipsaw on ordinary 8.57 ATR volatility); do not initiate new longs as the reward-to-risk to Target 1 ($248.30) is only 0.88:1 and confirmation requires a close above $248.30 on ≥7M volume with RSI >55. Stage re-engagement with half-tranche on confirmed breakout and consider covered calls at $245-$250 for October expiry as asymmetric structure over passive exposure.

Outcome

✗

Return

+1.67%

Status

scored

Trim IBM to 40% allocation (Underweight) following Q2 2026 deceleration to +1.1% YoY revenue, 160bps QoQ margin compression, and flat net income that contradict the bullish inflection thesis, while preserving 60% of the defensive ballast (2.88% dividend, 5.6% FCF yield, 0.705 beta) given the 24.7% drawdown already pricing significant pessimism; hard stop at $215, with Q3 2026 earnings as the next re-evaluation catalyst.

Outcome

✗

Return

-2.33%

Status

scored

Maintain IBM at full benchmark weight (100%) through Q3 2026 earnings, rejecting the sixth consecutive iteration of the same bearish thesis which has failed to catalyze in all five prior calls. The decision anchors on the 8/13 lesson log showing that 'modestly below' compromise sizing produced negative alpha in five of five iterations, and commits to full benchmark exposure with a defined upgrade trigger at $245+ reclaim (volume + RSI >55) or Q3 beat-and-raise with HashiCorp disclosure.

Outcome

✓

Return

-1.19%

Status

scored

Maintain IBM at 75-90% benchmark weight (Hold) rather than initiating fresh longs or executing aggressive trims; trim into rallies at $242-250 on declining volume with hard stop at $211. Upgrade to Buy only on confirmed 50 SMA reclaim above $252.10 with volume and RSI >55, material OpenAI contract disclosure, or Q3 2026 earnings beat-and-raise. The fifth consecutive bearish iteration carries negative marginal information value given persistent constructive signals (MACD positive 8 sessions, VWMA rising $213.90→$227.15, higher-low structure from $204.30).

Outcome

✓

Return

+0.49%

Status

scored

Maintain IBM at or modestly below benchmark weight through Q3 2026 earnings (mid-October) while collecting the 2.84% dividend as compensation for the binary event risk. Optional half-sized scale-in permitted on $232 close with 10 EMA support and RSI >45, with full re-engagement on $245 reclaim with volume and RSI >55 or clean Q3 beat-and-raise with HashiCorp disclosure. Hard stop at $211 on daily close with volume >15M shares.

Outcome

✓

Return

-1.02%

Status

scored

Maintain IBM at benchmark weight with a Hold rating; do not initiate new longs at $236 but do not aggressively trim either, as two prior bearish calls failed to catalyze despite correctly identified structural risks. Keep the $217 stop loss as downside discipline while optionally adding a half-sized starter position on pullbacks to $221-231 if RSI stays above 40 and the 10 EMA holds.

Outcome

✓

Return

+0.89%

Status

scored

Hold IBM at 3-4% portfolio weight (2.85% yield, 28 years of dividend growth) while technical structure bases. Do not add on the basing pattern alone—wait for confirmed close above $242.26 with volume >20% above 20-day average, or trim 25-33% if price closes below $199. Q3 2026 earnings (late October) is the binary catalyst.

Outcome

–

Return

-0.41%

Status

scored

Trim IBM to 30-40% of benchmark weight with a $242 stop loss. The position faces five interlocking risks: an undisclosed legal overhang causing the July 14 crash, a confirmed death cross with anemic 3.69M bounce volume versus 10-67M during the crash, sharply decelerating FCF ($2.21B Q2 vs $4.78B Q1), structural balance sheet vulnerability (58% goodwill, 0.79 current ratio), and insufficient near-term catalysts. Calendar Q3 2026 earnings as the binary catalyst for re-evaluation.